leadf
logo-loader
viewXPhyto Therapeutics Corp.

XPhyto Therapeutics could have its rapid disposable coronavirus test on the market early next year

Work has progressed so rapidly in recent weeks the pair are targeting regulatory approval for the product in the first three months of next year

XPhyto Therapeutics Corp. -
Bringing us up to date on progress with areas such as advanced prototype production and usability testing will be CEO Hugh Rogers

XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) (FRA:4XT) has partnered with a company called 3a-Diagnostics to develop a rapid disposable COVID-19 test.

Work has progressed so rapidly in recent weeks the pair are targeting regulatory approval for the product in the first three months of next year.

Bringing us up to date on progress with areas such as advanced prototype production and usability testing will be CEO Hugh Rogers.

Catch up with Hugh at the Proactive Virtual Forum on Tuesday October 27, from 1pm EST.

CLICK HERE TO REGISTER

About the event:

  • Ours is an audience of astute high net worth investors, fund managers, private client brokers and analysts
  • We look beyond the numbers and meet the people creating the value for shareholders

The format:

  • Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story
  • You can watch the event afterwards on our YouTube channel

CLICK HERE TO REGISTER

Quick facts: XPhyto Therapeutics Corp.

Price: 2.26 CAD

CSE:XPHY
Market: CSE
Market Cap: $137 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of XPhyto Therapeutics Corp. named herein, including the promotion by the Company of XPhyto Therapeutics Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

XPhyto Therapeutics continues to move toward commercialization of their...

XPhyto Therapeutics (CSE: XPHY- OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive to provide an update on their plans to go to market in Europe with their testing program for the COVID-19 Rogers talks about where that program is AT and also about their drug delivery platform...

4 weeks, 1 day ago

2 min read